Background: Articular cartilage is a unique tissue in that it is avascular with its nutrition and oxygen supply being dependent on the diffusion of solutes through the synovial fluid and to and from the subchondral bone. The oxygen levels in articular cartilage, therefore, are assumed to be low. Oxygen is an important modulator of gene expression and this regulation occurs largely through the activation of the transcriptional complex hypoxia-inducible factor-1 (HIF-1). However, little is known about how articular cartilage regulates genes in response to O 2 tension and whether this regulation occurs through HIF-1.
Introduction
It is well known that articular cartilage is an avascular tissue that derives its nutrition and oxygen supply by diffusion from the synovial fluid and the subchondral bone. It has been estimated that the chondrocytes at the articular surface are exposed to approximately 6 to 10% O 2 whereas the chondrocytes in the deepest layers of the articular cartilage may have access to only 1 to 6% O 2 or less [1] [2] [3] [4] [5] [6] [7] .
Other studies have shown that articular chondrocytes derive up to 75% of their ATP requirement from anaerobic glycolysis, underlining their adaptation to a low O 2 environment 8, 9 . However, the mechanisms by which articular chondrocytes regulate genes that are sensitive to O 2 levels under normal and pathological conditions remain poorly understood.
The role of oxygen as an important modulator of gene expression is well recognized and extensive evidence implicates hypoxia-inducible factor (HIF-1) as the primary gene regulatory factor that responds to variations in O 2 levels 10 . HIF-1 is a heterodimer consisting of two different subunits, HIF-1 and HIF-1 , (also known as ARNT-arylhydrocarbon receptor nuclear translocator) that are members of the bHLH-PAS (basic helix-loop-helix-PER-ARNT-SIM) family of transcription factors 11, 12 . HIF-1 is constitutively expressed, whereas exposure to hypoxia inhibits the rapid proteosome-mediated degradation of HIF-1 , thereby increasing the steady-state levels of HIF-1 protein in the cell 13, 14 . Once HIF-1 protein levels are stabilized, it can translocate to the nucleus, dimerize with HIF-1 and bind to regulatory regions of hypoxia-responsive genes through the hypoxia response element (HRE) leading to their transcriptional activation 15, 16 . Genes that are regulated by HIF-1 in response to O 2 tension include those encoding growth and angiogenic factors, glycolytic enzymes and glucose transporters ( 17 and refs. therein). Indeed, it has been demonstrated that mammalian cells lacking HIF-1 show decreased growth rates during both hypoxia and normoxia, as well as decreased levels of mRNA for multiple glycolytic enzymes and glucose transporters 18 . The diminishing glycolytic capacity results in lowered free ATP levels in hypoxic cells and, therefore, HIF-1 activation is an important control mechanism of the metabolic state during hypoxia 19 . It has become increasingly clear, however, that HIF-1 levels are regulated by factors other than O 2 levels. Recent work has shown that growth factors, such as IGF-1 and 2, and cytokines, such as IL-1 and TNF , can influence the levels of HIF-1 protein and HIF-1 DNA-binding activity within the cell 20 . Interestingly, both cytokines and growth factors generally cause an induction of HIF-1 levels or HIF-1 DNA-binding activity, albeit most likely through different mechanisms. Indeed, recent evidence indicates that IGF-1 acts to increase HIF-1 levels by influencing the translation of HIF-1 mRNA whereas TNF-may regulate HIF-1 by increasing its stability and nuclear translocation in a NF-B dependent manner [21] [22] [23] [24] .
Since it is assumed that articular cartilage is normally hypoxic as compared to vascularized tissues, there has been investigation into the effect of low O 2 tension on the growth and phenotype of articular cartilage in vitro. These studies have substantiated the notion that chondrocytes are well adapted to an hypoxic environment and that culture in a low O 2 tension environment may be beneficial for maintenance of the chondrocyte-specific phenotype in vitro 8, 25 . Indeed, culture of articular chondrocytes in a low O 2 environment has been shown to augment chondrocyte-specific gene expression and speed recovery of the differentiated phenotype following loss of their chondrocyte-specific phenotype during monolayer culture [26] [27] [28] [29] . It has been postulated that during degenerative joint diseases such as OA, the O 2 gradient across articular cartilage may be altered due to cartilage thinning and erosion, changes in extracellular matrix composition, and the development of cartilage fissures 5, 26 . However, very little is known about how articular chondrocytes regulate gene expression in response to varying O 2 concentrations under normal and pathological situations, and to what extent HIF-1 is involved in the response. We recently reported that HIF-1 mRNA levels are down-regulated in de-differentiated chondrocytes as compared to differentiated chondrocytes and we have also detected HIF-1 transcripts in both human adult normal and OA chondrocytes 30 . The aim of the present study was to investigate the expression profile of HIF-1 in normal and OA human chondrocytes under normoxic and hypoxic conditions and in response to treatment with TNF-and to investigate the localization of HIF-1 in human articular cartilage.
Materials and methods

ISOLATION AND CULTURE OF HUMAN NORMAL AND OA CHONDROCYTES
Human chondrocytes were obtained from the femoral condyles and tibial plateaus of patients with OA that underwent knee-joint replacement surgery at Thomas Jefferson University Hospital and from normal donors at autopsy through the National Disease Research Interchange or the Cooperative Human Tissue Network following procedures approved by the Institutional Review Board. The chondrocytes were isolated from all remaining cartilage tissue as previously described 31 . Briefly, to remove adherent fibrous tissues, the cartilage was incubated in Hanks' medium containing trypsin and bacterial collagenase (2 mg/ml each) for 1 h at 37°C. The medium was discarded and the tissue fragments minced and digested overnight at 37°C in Dulbecco's minimum essential medium (DMEM) with 4.5 g/l glucose containing 10% fetal bovine serum and 0.5 mg/ml bacterial collagenase. The released cells were filtered through a 70 µm nylon cell strainer and were collected by centrifugation at 250×g for 5 min and washed four times with collagenase-free medium. Isolated chondrocytes were immediately frozen in freezing media (90% FBS, 10% DMSO) and stored for future experiments. For experiments involving suspension cultured chondrocytes, which preserves the differentiated phenotype, cells were thawed and plated into suspension in 6-well ultralow attachment plates (Corning, Acton, MA) at a density of 1×10 6 /ml. The cells were allowed to recover for 48 h at which time they were utilized for experiments. Chondrocytes utilized for experiments in suspension culture were not cultured in monolayer before use. For experiments involving monolayer cultures of chondrocytes, cells were thawed and plated into 162 cm 2 plastic tissue culture flasks at a density of 30 000/cm 2 and cultured for 30 days through three passages. All cultures were grown in DMEM containing 10% FBS, 2 mM glutamine, 1% vitamin supplements, 100 units/ml penicillin and 100 µg/ml streptomycin. Amphotericin B and ascorbic acid were avoided because they can interfere with HIF-1 expression 32 . For normoxic conditions, cells were maintained at 37°C in 5% CO 2 and 95% air (21% O 2 ). To subject the cells to hypoxia, cultures were placed in a modular incubator chamber (Billups-Rothenburg, Del Mar, CA) that had been flushed with a mixture of 1% O 2 , 5% CO 2 and 94% N 2 . Hypoxic conditions within the chamber were verified with a YSI model 55 dissolved oxygen meter (YSI Inc., Yellow Springs, OH). TNF was purchased from Pierce Endogen (Rockford, IL). For TNF treatment, chondrocytes were cultured for 18 h in media containing 0.5% serum followed by a 4 h treatment with 10ng/ml TNF-in media containing 0.5% serum.
RNA ISOLATION AND NORTHERN HYBRIDIZATION ANALYSIS
Total cellular RNA was isolated from human HTB chondrosarcoma cells and human normal and OA chondrocytes utilizing the Trizol reagent (Life Technologies, Rockville, MD) according to the manufacturer's specifications. HTB chondrosarcoma poly-A+ RNA was obtained using the Oligotex mRNA kit from Qiagen (Valencia, CA). cDNA for human HIF-1 , -2 and-1 for use as probes in Northern analyses were obtained from HTB poly-A+ RNA by reverse transcriptase-polymerase chain reaction (RT-PCR). First strand cDNA was generated using Superscript II reverse transcriptase (Life Technologies) and oligo-dT as a primer. PCR was performed with the Expand High Fidelity Polymerase System (Roche Diagnostics, Indianapolis, IN) and PCR products were cloned into the pCR-Blunt vector (Invitrogen, Carlsbad, CA). The following primer pairs were used: HIF-1 , ACCATGCCCCAGATTCAGGA (forward) and ATCAGTGGTGGCAGTGGTAGTGGT (reverse); HIF-2 , GGGGATCAGCGCACAGAGTT (forward) and TGG GCTGACGACAGGCTGTA (reverse); HIF-1 , GGTCCCAC AGCTAATTTACC (forward) and ATCTGTCCTGCAGAAG CTGA (reverse). The PCR conditions were an initial denaturation of 94 o C for 2 min followed by 32 cycles of 94 o C for 30 s, 63 o C for 30 s and 72 o C for 1 min and then a finishing step of 72 o C for 5 min. The identity of the cDNA clones was verified by sequencing with an ABI automatic sequencer (Perkin-Elmer, Norwalk, CT).
For Northern analyses, 8 µg of total RNA from two different normal and two different OA human chondrocyte isolates was electrophoresed on 1% agaroseformaldehyde gels and transferred to Hybond-N+ or XL membranes (Amersham Pharmacia Biotech, Piscataway, NJ) as described previously 30 . The blots were hybridized in 5× SSC, 2× Denhardt's solution, 50% formamide, 0.1-0.5% SDS and 0.1 mg/ml denatured salmon sperm DNA at 42°C for 18 h with 32 P-labeled cDNA probes. The blots were washed to a stringency of 0.2× SSC/0.1% SDS at 65°C for 30 min and then exposed to a phosphor imaging cassette. A cDNA probe for human GAPDH was included in the hybridizations as a control for variation in loading of the gels.
PREPARATION OF NUCLEAR EXTRACTS AND WESTERN ANALYSES
Nuclear extracts were prepared from isolated chondrocytes according to the method of Dignam et al. 33 , using the CellLytic NuCLEAR extraction kit (Sigma-Aldrich, St. Louis, MO). Briefly, cells were placed in hypotonic buffer (10 mM HEPES [pH 7.9], 1.5 mM MgCl 2 , 10 mM KCl, and 0.5 mM DTT) and incubated on ice for 15 min. Igeapal CA-630 was added to a final concentration of 0.6% and the mixture was vortexed vigorously for 10 s. Nuclei were recovered by centrifugation at 3300×g for 30 s at 4°C and extracted in buffer containing 20 mM HEPES pH 7.9, 0.42 M NaCl, 25% glycerol, 1.5 mM MgC1 2 , 0.2 mM EDTA, and 0.5 mM DTT for 30 min at 4°C by gentle shaking. The extract was centrifuged for 15 min at 25 000×g, and the supernatant was then frozen at −70 o C. All buffers contained a protease inhibitor mixture (2 mM 4-(2-aminoethyl) benzenesulfonylfluoride, 1.4 pM trans-epoxysuccinyl-L-leucylamido [4-guanidinobutane], 130 pM bestatin, 1 µM leupeptin, 0.3 pM aprotinin, Sigma-Aldrich) and 2.6 µM calpain inhibitor I (Calbiochem, San Diego CA).
For Western analysis, 35-50 µg of chondrocyte nuclear extract was separated on 8% SDS-polyacrylamide gels and transferred to Hybond-P membranes (Amersham Pharmacia Biotech) in 20 mM Tris, 150 mM glycine and 20% methanol at 40V for 18 h at 4°C. The membranes were blocked with PBS wash solution containing 5% nonfat milk and 0.1% Tween 20 (PBSMT). The primary antibody was a mouse monoclonal anti-HIF-1 antibody (1/250 dilution, Transduction Laboratories, Lexington, KY) and the secondary antibody was a horse anti-mouse IgG-horseradish peroxidase conjugate (1/2000 dilution, Vector Laboratories, Burlingame, CA). The membranes were washed 3 times (1×15 min and 2×10 min) each between antibody incubations with PBMST. The blots were developed using the ECL detection kit (Amersham Pharmacia Biotech).
IMMUNOFLUORESCENCE
Slices of normal and OA cartilage from one donor each were frozen in liquid N 2 -cooled 2-methylbutane in OCT freezing medium (Miles, Elkhart, IN) and maintained at -80°C. The immunofluorescence was carried out by the method of Schipani et al 34 . Frozen sections (6 microns) were fixed in acetone for 20 min at -20°C and then permeabilized with 0.1% Triton X-100 in 0.1% sodium citrate. After blocking with 1.5% normal goat serum in PBS/1% BSA, sections were incubated with a rabbit polyclonal anti-HIF-1 antibody (H206, Santa Cruz Biotechnology, Santa Cruz, CA) at a dilution of 1:100. Binding was revealed by employing a biotinylated goat anti-rabbit IgG (1/250 dilution, Pierce, Rockford, IL), and the detection carried out with streptavidin-Texas red (1/300 dilution, Pierce). Images were obtained with an Olympus inverted confocal microscope.
Results
EXPRESSION OF HIF-1 , -2 AND 1 mRNA IN HUMAN CHONDROCYTES
We recently reported the detection of HIF-1 mRNA expression in human OA cartilage by RT-PCR. Here, we confirmed and extended those results by performing Northern analyses on RNA extracted from human normal and OA chondrocytes which had been cultured under normoxic conditions employing cDNA probes for HIF-1 , -2 and -1 . Fig. 1 shows that HIF-1 mRNA was readily detected in normoxic human normal and OA chondrocytes. We also detected mRNA for HIF-1 which is constitutively expressed by numerous cell types. Interestingly, mRNA for HIF-2 was also detected in both normal and OA chondrocytes. HIF-2 expression has previously been detected in developing kidney and lung, and in vascular endothelial and osteoblastic cells 35, 36 .
DIFFERENTIATED CHONDROCYTES EXPRESS HIF-1 PROTEIN UNDER NORMOXIC CONDITIONS
Normally, HIF-1 protein levels are undetectable in cells under normoxic conditions, however, the expression profile of HIF-1 in articular cartilage, an avascular-hypoxic tissue, is not known. In order to determine whether articular chondrocytes express HIF-1 protein under normoxic conditions, nuclear extracts were prepared from human OA chondrocytes cultured either in suspension (differentiated) or as monolayers in plastic tissue culture flasks (de-differentiated) and then Western blot analysis was performed with anti-HIF-1 antibodies. Surprisingly, we detected a strong HIF-1 signal in differentiated articular chondrocytes cultured in suspension under normoxic conditions ( Fig. 2A ). In agreement with our earlier studies in which we observed a down-regulation of HIF-1 mRNA in de-differentiated chondrocytes 30 , we could not detect HIF-1 protein by Western analysis in de-differentiated human OA chondrocytes ( Fig. 2A) . In order to verify our observation of HIF-1 expression in chondrocytes under normoxic conditions, we performed Western analysis on nuclear extracts from chondrocytes isolated from six other donors; four from patients with OA and two normal donor samples. We detected HIF-1 expression in all six samples as can be seen in the Western analyses shown in Fig. 2B .
INDUCTION OF HIF-1 IN ARTICULAR CHONDROCYTES BY HYPOXIA
We next determined whether hypoxia would induce higher levels of HIF-1 in OA or normal articular chondrocytes in culture. Utilizing a hypoxic incubation chamber we first determined the dissolved O 2 levels in cell culture media after purging the chamber with a mixture of 94% N 2 , 5% CO 2 and 1% O 2 . As can be seen in Fig. 3A , hypoxic conditions in the media were achieved within 1 h of purging and remained stable for up to 16 h. This was further verified by subjecting HEP-3B cells to a 4 h hypoxic treatment in the chamber followed by immunofluorescence to detect HIF-1 expression ( Fig. 3B ). OA or normal articular chondrocytes that were cultured in suspension were subjected to a hypoxic treatment of 1% O 2 for 0, 4, 8 or 16 h. Nuclear extracts were then prepared and HIF-1 protein levels were determined by Western analysis. As can be seen in Fig. 3C -E, exposure of either normal or OA articular chondrocytes to hypoxic conditions for increasing lengths of time resulted in a modest increase in the HIF-1 signal. We also observed that the HIF-1 bands became consolidated into a single higher molecular weight band during the hypoxic treatment. Whether this is due to a decrease in degradation, an increase in phosphorylation, or both, remains to be determined. Finally, as a control for overall HIF-1 induction, we performed an induction experiment with the hypoxia mimic CoCl 2 . As can be seen in Fig. 3F , HIF-1 is readily inducible in normal human articular chondrocytes upon a 4 h treatment with 100 µM CoCl 2 .
LOCALIZATION OF HIF-1 IN ARTICULAR CARTILAGE
In order to verify the results obtained with the chondrocyte cell cultures, we next performed immunofluorescence analysis for HIF-1 expression on frozen sections of OA and normal cartilage. The sections were probed with a rabbit polyclonal anti-HIF-1 antibody and the presence of HIF-1 was revealed with anti-rabbit IgG-biotin and streptavidin-Texas-red by confocal microscopy. Fig. 4 shows that HIF-1 could be readily detected in the nuclei of chondrocytes within the normal cartilage sections. A similar result was obtained when fresh frozen sections of OA human adult articular cartilage were probed with anti-HIF-1 antibody (Fig. 5 ).
REGULATION OF HIF-1 IN OA AND NORMAL CHONDROCYTES BY TNF-
Pro-inflammatory cytokines, such as TNF-, play a major role in the pathogenesis of degenerative joint disease. TNF-has been implicated in the regulation of HIF-1 in other cell types and has been shown to modulate HIF-1 levels in a non-hypoxia dependent manner 23, 24 . Therefore, we decided to investigate whether TNF-treatment of human articular chondrocytes had any effect on the levels of HIF-1 under normoxic conditions. Fig. 6 shows that treatment of normal or OA chondrocytes with 10 ng/ml TNF-for 4 h resulted in an increase in the steady-state levels of HIF-1 . The increase in HIF-1 levels upon treatment with TNF-was partially abrogated by pretreatment of the cells with either the p38 kinase inhibitor SB203580 or the NF-B inhibitor pyrrolidine dithiocarbamate (PDTC). We conclude, therefore, that TNFregulates HIF-1 levels in chondrocytes, at least in part, through NF-B and p38 MAPkinase mediated pathways.
Discussion
The results presented in this study demonstrate for the first time the expression of HIF-1 and HIF-2 in human adult articular cartilage. The most important and provocative finding was that the expression of HIF-1 by cultured human articular chondrocytes could be readily detected under normoxic conditions. Furthermore, human articular chondrocytes that were grown in suspension culture under ambient O 2 levels (21%) to preserve the differentiated phenotype exhibited an easily detectable level of HIF-1 protein expression as determined by immunoblotting, whereas chondrocytes that had become de-differentiated by culture in monolayer did not exhibit detectable HIF-1 expression. When cultured human OA and normal articular chondrocytes were exposed to hypoxia (1% O 2 ) for up to 16 h, a modest increase in HIF-1 levels was observed. In some cases we observed a closely-spaced set of HIF-1 bands by immunoblotting. A closely spaced set of bands for HIF-1 has been observed by others and has been shown to be caused, at least in part, by phosphorylation of HIF-1 through the activity of the extracellular signal reponse kinases (ERKs) 37 . Interestingly, the presence of the lower molecular weight HIF-1 bands was mostly abrogated in articular chondrocytes in response to increasing duration of exposure to hypoxia. In other cell types hypoxia has been shown to induce the activity of ERKs 38, 39 . It remains to be determined whether the increase in the higher molecular weight HIF-1 bands upon hypoxic treatment of articular chondrocytes was the result of increased phosphorylation, decreased degradation, or both. We also demonstrated that treatment of OA and normal articular chondrocytes with TNF resulted in an increase in the steady state levels of HIF-1 . Pretreatment of the chondrocyte cultures with inhibitors of p38 MAP kinase or NF-B partially abrogated the increase in HIF-1 levels in response to TNF . Articular cartilage, an avascular tissue, derives its oxygen and nutrient supply from the synovial fluid and to some extent from the underlying subchondral bone, with some of the chondrocytes in the deepest layers being up to 3-5 mm from a supply artery 6 . This has led to the assumption that articular cartilage is normally in a hypoxic environment as compared to vascularized tissues. Measurement of O 2 concentrations in synovial fluid and joint tissues along with in vitro studies support this view [1] [2] [3] [4] [5] [6] [7] [26] [27] [28] [29] . We observed HIF-1 expression in chondrocytes cultured in suspension and in sections of articular cartilage but not in chondrocytes that had been de-differentiated by monolayer culture conditions. HIF-1 protein expression therefore correlates with the differentiated chondrocyte phenotype and our results lend support to the notion that cartilage is generally a hypoxic tissue. The aggregates and nodules of cartilagelike tissue that form in the suspension culture system utilized in the present work may result in a hypoxic environment thereby triggering the expression of HIF-1 in vitro. Interestingly, HIF-1 has been found to play a role in chondrocyte function and survival in the endochondral growth plate in vivo 34 . When a targeted deletion of the HIF-1 gene in the cartilaginous growth plate of mice was performed, the chondrocytes within the interior of the growth plate, which are presumed to be hypoxic, underwent cell death. Furthermore, HIF-1 was found to be essential for the expression of the glycolytic enzyme phosphoglycerate kinase-1 in growth plate chondrocytes, indicating that a decrease in glyocolytic activity may have contributed to the observed cell death 34 . A similar role for HIF-1 in articular chondrocyte metabolism remains to be established.
Recent investigations have revealed that HIF-1 is regulated by factors other than hypoxia. Of pertinent interest to the field of chondrocyte biology and arthritis are the findings that HIF-1 levels and HIF-1 DNA-binding activity can be modulated by pro-inflammatory cytokines such as IL-1 and TNF-, and also by growth factors and hormones such as TGF-, IGF-1 and -2 and insulin. Indeed, HIF-1 was shown to be involved in the induction of insulin and IGFresponsive genes including glucose transporter and glycolytic enzyme genes, and VEGF [40] [41] [42] . Even more recent work has elucidated that the activation of HIF-1 by insulin and insulin-like growth factors proceeds through a pathway dependent upon PI-3 kinase and MAP kinase in retinal epithelial, HepG2 and colon carcinoma cells, a regulatory mechanism distinct from that of hypoxia 21, 43, 44 . However, in other work, insulin and IGF-1 stabilized HIF-1 in L8 myoblasts in a manner similar to hypoxic regulation 40 . Moreover, IGF-2 and IGF-binding proteins 2 and 3 are HIF-1 target genes implicating HIF-1 in an IGF stimulated autocrine loop 42, 45 . Although the mechanism of HIF-1 activation by insulin and IGFs may be different in different cell types, the implications for articular chondrocytes are important, especially since IGF-1 and-2 are considered to be autocrine survival factors for these cells 46 . Interestingly, the work herein and other investigations into the regulation of HIF-1 by cytokines such as IL-1 and TNF-has revealed that they also cause an induction of HIF-1 23, 47, 48 . In support of our findings that induction of HIF-1 in chondrocytes by TNF-is, at least in part, modulated through NF-B, induction of HIF-1 in NIH3T3 fibroblasts has also been reported to be mediated through activation of NF-B 23 . Similarly, p38 has been implicated in the induction of HIF-1 expression by thrombin in human vascular smooth muscle cells 49 .
We also demonstrated the expression of HIF-2 mRNA in both normal and OA human articular chondrocytes. HIF-2 was originally described as an endothelial cell specific factor, however, more recent results indicate a more widespread expression pattern 35 . HIF-2 can activate some of the same genes as HIF-1 , including erythropoietin and VEGF, and recent work indeed indicates that HIF-2 can activate a subset of the genes inducible by HIF-1 50 . Interestingly, this subset does not include the glycolytic genes that can be induced by hypoxia through HIF-1 50 . The functional significance of the HIF-2 mRNA expression in human articular chondrocytes observed in this work is currently being investigated.
It is believed that chondrocytes are the source of TNFexpression found in OA and that chondrocytes respond to TNF-in a catabolic fashion including the production of other inflammatory cytokines such as IL-1 and IL-8 51 .
Modulation of the metabolic status of chondrocytes in response to these cytokines is well established and it is interesting to speculate that some of this modulation occurs through a HIF-1 mediated pathway. In support of this notion, it has been reported that both IL-1 and TNFincrease glucose transport in human articular chondrocytes and up-regulate mRNA expression of glucose transporters, which are HIF-1 target genes 52 . We are currently trying to determine the subset of genes that are activated through HIF-1 by pro-inflammatory cytokines in articular chondrocytes. In conclusion, since HIF-1 modulates the activity of a large number of genes relevant to chondrocyte metabolism, growth, survival, and differentiation, the findings in this work concerning the expression of HIF-1 in articular chondrocytes and its induction by cytokines has important implications for its role in the regulation of the chondrocyte-specific phenotype in both normal and pathological situations.
